Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 106

1.

Enzymatic strategies to detoxify gluten: implications for celiac disease.

Caputo I, Lepretti M, Martucciello S, Esposito C.

Enzyme Res. 2010 Oct 7;2010:174354. doi: 10.4061/2010/174354.

2.

Proteomic analysis in allergy and intolerance to wheat products.

Mamone G, Picariello G, Addeo F, Ferranti P.

Expert Rev Proteomics. 2011 Feb;8(1):95-115. doi: 10.1586/epr.10.98. Review.

PMID:
21329430
3.

Emerging therapeutic options for celiac disease: potential alternatives to a gluten-free diet.

Bakshi A, Stephen S, Borum ML, Doman DB.

Gastroenterol Hepatol (N Y). 2012 Sep;8(9):582-8.

4.

Treatment of celiac disease: from gluten-free diet to novel therapies.

Francavilla R, Cristofori F, Stella M, Borrelli G, Naspi G, Castellaneta S.

Minerva Pediatr. 2014 Oct;66(5):501-16. Review.

PMID:
24938882
5.

Celiac sprue.

Cárdenas A, Kelly CP.

Semin Gastrointest Dis. 2002 Oct;13(4):232-44. Review.

PMID:
12462708
6.

Sensitive detection of cereal fractions that are toxic to celiac disease patients by using monoclonal antibodies to a main immunogenic wheat peptide.

Morón B, Cebolla A, Manyani H, Alvarez-Maqueda M, Megías M, Thomas Mdel C, López MC, Sousa C.

Am J Clin Nutr. 2008 Feb;87(2):405-14.

7.

Toward the assessment of food toxicity for celiac patients: characterization of monoclonal antibodies to a main immunogenic gluten peptide.

Morón B, Bethune MT, Comino I, Manyani H, Ferragud M, López MC, Cebolla A, Khosla C, Sousa C.

PLoS One. 2008 May 28;3(5):e2294. doi: 10.1371/journal.pone.0002294.

8.

Toxic, immunostimulatory and antagonist gluten peptides in celiac disease.

Silano M, Vincentini O, De Vincenzi M.

Curr Med Chem. 2009;16(12):1489-98. Review.

PMID:
19355902
9.

The gluten-free diet: testing alternative cereals tolerated by celiac patients.

Comino I, Moreno Mde L, Real A, Rodríguez-Herrera A, Barro F, Sousa C.

Nutrients. 2013 Oct 23;5(10):4250-68. doi: 10.3390/nu5104250. Review.

10.

Antagonist peptides of the gliadin T-cell stimulatory sequences: a therapeutic strategy for celiac disease.

Silano M, Vincentini O, Iapello A, Mancini E, De Vincenzi M.

J Clin Gastroenterol. 2008 Sep;42 Suppl 3 Pt 2:S191-2. doi: 10.1097/MCG.0b013e31817df76a.

PMID:
18685513
11.

Monitoring of gluten-free diet compliance in celiac patients by assessment of gliadin 33-mer equivalent epitopes in feces.

Comino I, Real A, Vivas S, Síglez MÁ, Caminero A, Nistal E, Casqueiro J, Rodríguez-Herrera A, Cebolla A, Sousa C.

Am J Clin Nutr. 2012 Mar;95(3):670-7. doi: 10.3945/ajcn.111.026708. Epub 2012 Jan 18.

12.

Identification and analysis of multivalent proteolytically resistant peptides from gluten: implications for celiac sprue.

Shan L, Qiao SW, Arentz-Hansen H, Molberg Ø, Gray GM, Sollid LM, Khosla C.

J Proteome Res. 2005 Sep-Oct;4(5):1732-41.

13.

Future therapeutic options for celiac disease.

Sollid LM, Khosla C.

Nat Clin Pract Gastroenterol Hepatol. 2005 Mar;2(3):140-7. Review.

PMID:
16265155
14.

Consistency in polyclonal T-cell responses to gluten between children and adults with celiac disease.

Hardy MY, Girardin A, Pizzey C, Cameron DJ, Watson KA, Picascia S, Auricchio R, Greco L, Gianfrani C, La Gruta NL, Anderson RP, Tye-Din JA.

Gastroenterology. 2015 Nov;149(6):1541-1552.e2. doi: 10.1053/j.gastro.2015.07.013. Epub 2015 Jul 29.

PMID:
26226573
15.

Testing safety of germinated rye sourdough in a celiac disease model based on the adoptive transfer of prolamin-primed memory T cells into lymphopenic mice.

Freitag TL, Loponen J, Messing M, Zevallos V, Andersson LC, Sontag-Strohm T, Saavalainen P, Schuppan D, Salovaara H, Meri S.

Am J Physiol Gastrointest Liver Physiol. 2014 Mar;306(6):G526-34. doi: 10.1152/ajpgi.00136.2013. Epub 2014 Jan 23.

PMID:
24458020
16.

Future treatment strategies for celiac disease.

Lindfors K, Lähdeaho ML, Kalliokoski S, Kurppa K, Collin P, Mäki M, Kaukinen K.

Expert Opin Ther Targets. 2012 Jul;16(7):665-75. doi: 10.1517/14728222.2012.688808. Epub 2012 May 24. Review.

PMID:
22620264
17.

In vitro models for gluten toxicity: relevance for celiac disease pathogenesis and development of novel treatment options.

Lindfors K, Rauhavirta T, Stenman S, Mäki M, Kaukinen K.

Exp Biol Med (Maywood). 2012 Feb;237(2):119-25. doi: 10.1258/ebm.2011.011294. Epub 2012 Jan 26. Review.

PMID:
22282398
18.

Detoxification of gluten by means of enzymatic treatment.

Wieser H, Koehler P.

J AOAC Int. 2012 Mar-Apr;95(2):356-63.

PMID:
22649919
19.

A quantitative analysis of transglutaminase 2-mediated deamidation of gluten peptides: implications for the T-cell response in celiac disease.

Dørum S, Qiao SW, Sollid LM, Fleckenstein B.

J Proteome Res. 2009 Apr;8(4):1748-55. doi: 10.1021/pr800960n.

PMID:
19239248
20.

Supplemental Content

Support Center